IMAX Corporation (NYSE:IMAX - Free Report) - Equities researchers at Wedbush upped their Q1 2026 earnings per share (EPS) estimates for shares of IMAX in a research note issued to investors on Monday, September 22nd. Wedbush analyst A. Reese now forecasts that the company will post earnings of $0.20 per share for the quarter, up from their previous forecast of $0.19. Wedbush currently has a "Outperform" rating and a $39.00 target price on the stock. The consensus estimate for IMAX's current full-year earnings is $0.91 per share. Wedbush also issued estimates for IMAX's Q4 2026 earnings at $0.53 EPS.
IMAX has been the topic of a number of other reports. Wells Fargo & Company upped their price objective on IMAX from $30.00 to $34.00 and gave the company an "overweight" rating in a report on Friday, July 25th. Roth Capital reaffirmed a "buy" rating and issued a $36.00 price target on shares of IMAX in a research note on Wednesday, July 9th. The Goldman Sachs Group reissued a "sell" rating on shares of IMAX in a research report on Friday, July 25th. Barrington Research upped their target price on shares of IMAX from $32.00 to $37.00 and gave the company an "outperform" rating in a research report on Friday. Finally, Benchmark increased their target price on shares of IMAX from $30.00 to $32.00 and gave the stock a "buy" rating in a research note on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.70.
Read Our Latest Research Report on IMAX
IMAX Price Performance
IMAX stock opened at $32.64 on Tuesday. The firm has a 50 day simple moving average of $28.11 and a 200-day simple moving average of $26.71. The stock has a market cap of $1.76 billion, a price-to-earnings ratio of 54.40, a price-to-earnings-growth ratio of 2.17 and a beta of 0.68. IMAX has a 1-year low of $18.76 and a 1-year high of $32.96.
IMAX (NYSE:IMAX - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.07. The firm had revenue of $91.68 million during the quarter, compared to analysts' expectations of $93.04 million. IMAX had a net margin of 9.04% and a return on equity of 8.62%. IMAX's revenue was up 3.1% compared to the same quarter last year. During the same period last year, the business earned $0.18 earnings per share.
IMAX announced that its board has approved a share buyback program on Thursday, June 12th that permits the company to buyback $100.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 6.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board believes its shares are undervalued.
Insider Transactions at IMAX
In other news, VP Robert D. Lister sold 20,000 shares of the firm's stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $32.80, for a total transaction of $656,000.00. Following the sale, the vice president owned 161,421 shares of the company's stock, valued at approximately $5,294,608.80. This trade represents a 11.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kenneth Ian Weissman sold 15,072 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $25.65, for a total value of $386,596.80. Following the completion of the transaction, the insider directly owned 26,133 shares of the company's stock, valued at $670,311.45. This trade represents a 36.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. 24.08% of the stock is owned by insiders.
Institutional Trading of IMAX
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IMAX. Caxton Associates LLP acquired a new position in shares of IMAX in the 2nd quarter valued at $228,000. Tower Research Capital LLC TRC raised its stake in IMAX by 194.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,148 shares of the company's stock worth $116,000 after acquiring an additional 2,740 shares in the last quarter. Orbis Allan Gray Ltd lifted its position in IMAX by 31.7% in the second quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company's stock valued at $142,960,000 after acquiring an additional 1,230,267 shares during the last quarter. HRT Financial LP boosted its stake in IMAX by 145.5% in the second quarter. HRT Financial LP now owns 103,271 shares of the company's stock valued at $2,887,000 after acquiring an additional 61,200 shares in the last quarter. Finally, Engineers Gate Manager LP grew its holdings in shares of IMAX by 152.3% during the second quarter. Engineers Gate Manager LP now owns 20,491 shares of the company's stock worth $573,000 after purchasing an additional 12,369 shares during the last quarter. Institutional investors and hedge funds own 93.51% of the company's stock.
About IMAX
(
Get Free Report)
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.